Bar-Ilan University, Israel — CureCurrent

How to interpret these research links

Connected source records

The exact organization name Bar-Ilan University, Israel appears in 12 distinct published trial records. The links retain registry-reported sponsor and collaborator roles; differently spelled legal entities are not automatically merged. Recruiting status describes the current published registry snapshot, not an independently verified availability guarantee.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Published trials12

Recruiting shown0

Roles2

SourceClinicalTrials.gov

Clinical trials

12 shown

Metacognitive and Insight Therapy for Persons With Schizophrenia (RCT MERIT)NCT03427580 · lead sponsor · 2018-03-01

Bubble: A New VR-AI Way of Treatment for Hot Flashes in Women With Breast CancerNCT04414033 · lead sponsor · 2018-02-01

Transcranial Direct Current Stimulation Influences on Cognitive Inhibition in SchizophreniaNCT01971073 · lead sponsor · 2015-01-01

T-Cell Repertoire Sequencing: Assessing Pembrolizumab Efficacy in Advanced Non-small Lung CancerNCT06045767 · collaborator · 2024-06-01

NOT_YET_RECRUITING

The Effects of a Digital Application for GDM Management in Improving Patients' ComplianceNCT05648721 · collaborator · 2023-05-18

Self-motion Perception in Parkinson's DiseaseNCT03137238 · collaborator · 2017-05-01

MISC-CBO in Children Affected by HIV/AIDSNCT04359043 · collaborator · 2017-02-01

Neurocognitive Performance During Hyperglycemia , and Brain Tissue Integrity in Youth With Type 1 Diabetes and in HealthyNCT02923323 · collaborator · 2016-03-01

The Neural Bases of Early Visual and Auditory Processing and Emotion Recognition Deficits in SchizophreniaNCT02588014 · collaborator · 2015-11-01

Evidence of Neuroplasticity After Performing a Cognitive Task in Idiopathic Parkinson's Disease PatientsNCT02494908 · collaborator · 2015-07-01

Minocycline add-on to Antipsychotics for the Treatment of Negative and Cognitive Symptoms in SchizophreniaNCT02907437 · collaborator · 2015-01-01

Magnetoencephalographic (MEG) Correlates of Negative Symptoms in Patients Suffering From Schizophrenia and Their Influence by Add-on TreatmentsNCT00894296 · collaborator · 2009-03-01

Sponsor roles

collaborator9

lead sponsor3

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.